Moreover, FTO knockdown in these ccRCC cells significantly prolonged the overall survival in mice with lung metastases (p=0.0004), and this effect was partially attenuated following 3-MA treatment (p= 0.0286, Fig. 5e). The gene discussed is FTO; the disease is nonpapillary renal cell carcinoma.